Ars Pharmaceuticals Inc (SPRY) Directors and Executive Officers - CSIMarket
CSIMarket
 
Ars Pharmaceuticals Inc   (NASDAQ: SPRY)

Ars Pharmaceuticals Inc

Officers & Directors


Peter Kolchinsky, Ph.D.
Director

Richard Lowenthal, M.S., MSEL
President, Chief Executive Officer, and Director

Peter A. Thompson, M.D.
Director

Laura Shawver, Ph.D.
Director

Kathleen D. Scott
Chief Financial Officer

Michael Kelly
Director

Pratik Shah, Ph.D.
Chairman of the Board of Directors

Phillip Schneider
Director

Brenton L. Saunders
Director

Rajeev Dadoo, Ph.D.
Director

Saqib Islam, J.D.
Director ,

Ars Pharmaceuticals Inc currently has 163 employees.






SPRY Management Effectiveness SPRY Revenue per Employee SPRY Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.